A case-cohort study of an early biomarker of lung cancer in a screening cohort of Yunnan Tin miners in China

Cancer Epidemiology Biomarkers and Prevention

Volumn 6, Issue 11, 1997, Pages 893-900

  Qiao, You Lin ^a   Tockman, Melvyn S ^b   Li, Li ^b   Erozan, Yener S ^b   Yao, Shu Xiang ^c   Barrett, Michael J ^d   Zhou, Wei Hong ^b   Giffen, Carol A ^d   Luo, Xue Chang ^c   Taylor, Philip R ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^d INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TIN;

ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER SCREENING; CHINA; COHORT ANALYSIS; CYTOLOGY; EARLY DIAGNOSIS; HUMAN; LUNG CANCER; MINER; PRIORITY JOURNAL; QUALITY CONTROL; SMOKING HABIT; TOBACCO;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ARSENIC; CASE-CONTROL STUDIES; CHINA; EPITHELIAL CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MASS SCREENING; MIDDLE AGED; MINING; NEOPLASM PROTEINS; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; RADON; RIBONUCLEOPROTEINS; SENSITIVITY AND SPECIFICITY; SPUTUM; TIN; TOBACCO SMOKE POLLUTION; TUMOR MARKERS, BIOLOGICAL;

EID: 16944365861     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Shaw, G. L., and Mulshine, J. L. Biomarkers and histology of premalignant and malignant lesions. In: P. Greenwald, B. S. Kramer, and D. L. Weed (eds.). Cancer Prevention and Control, pp. 111-133. New York: Marcel Dekker, Inc., 1995.
2. Saccomanno, G., Archer, V. E., Auerbach, O., Saunders, R. P., and Brennan, L. M. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer (Phila.), 33: 256-270, 1974.
3. Levin, M. L., Tockman, M. S., Frost, J. K., and Ball, W. C. Lung cancer mortality in males screened by chest X-ray and cytologic sputum examination: a preliminary report. Recent Res. Cancer Res., 82: 138-146, 1982.
4. Melamed, M. R., Flehinger, B. J., Zaman, M. B., Heelan, R. T., Perchick, W. B., and Martini, N. Screening for lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest, 86: 44-53, 1984.
5. Frost, J. K., Ball, W. C., Jr., Levin, M. L., Tockman, M. S., Baker, R. R., Carter, D., Eggleston, J. C., Erozan, Y. S., Gupta, P. K., and Khouri, N. F. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am. Rev. Respir. Dis., 130: 549-554, 1984.
6. Tockman, M. S., Levin, M. L., Frost, J. K., Ball, W. C., Jr., Stitik, F. P., and Marsh, B. R. Screening and detection of lung cancer. In: J. Aisner (eds.). Lung Cancer, pp. 25-40. New York: Churchill-Livingstone, Inc., 1985.
7. Tockman, M. S., Gupta, P. K., Myers, J. D., Frost, J. K., Baylin, S. B., Gold, E. B., Chase, A. M., Wilkinson, P. H., and Mulshine, J. Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells: a new approach to early lung cancer detection. J. Clin. Oncol., 6: 1685-1693, 1988.
8. Mulshine, J. L., Tockman, M. S., et al. Lung cancer: rational strategies for early detection and intervention. Oncology (Basel), 5: 25-32, 1991.
9. Tockman, M. S., Gupta, P. K., Pressman, N., and Mulshine, J. L. Consideration in bringing a cancer biomarker to clinical application. Cancer Res., 52 (Suppl.): 2711s-2718s, 1992.
10. Mao, L., Hruban, R. H., Boyle, J. O., Tockman, M. S., and Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res., 54: 1634-1637, 1994.
11. Zhou, J., Mulshine, J. L., Unsworth, E. J., Scott, F. M., Avis, I. M., Vos, M. D., and Treston, A. M. Identification of a heterogeneous nuclear ribonucleoprotein (hnRNP) as an early lung cancer detection marker. J. Biol. Chem., 277: 10760-10766, 1996.
12. Mulshine, J., Cuttitta, F., Bibro, M., et al. Murine monoclonal antibodies which distinguish non-small cell from small cell lung cancer. J. Immunol., 131: 497, 1983.
13. Rosen, S. T., Mulshine, J. L., Cuttitta, F.,et al. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies. Cancer Res., 44: 2052-2061, 1984.
14. Gupta, P. K., Myers, J. D., Baylin, S. B., Mulshine, J. L., Cuttitta, F., and Gazdar, A. F. Improved antigen detection in ethanol-fixed cytologic specimens. Modified avidin-biotin-peroxidase complex (ABC) method. Diagn. Cytopathol., 1: 133-136, 1985.
15. Tockman, M. S., Gupta, P. K., Pressman, N., and Mulshine, J. L. Cytometric validation of immunocytochemical observations in developing lung cancer. Diagn. Cytopathol., 9: 615-622, 1993.
16. Mountain, C. F. A new international staging system for lung cancer. Chest, 89 (Suppl.): 225s-233s, 1986.
17. Kreyberg, L. Histological typing of lung tumors. In: International Histological Classification of Tumors, Vol. 1. Geneva: WHO, 1967.
18. Tockman, M. S., Qiao, Y. L., Li, L., Zhao, G. Z., Sharma, R., Cavenough, L., and Erozan, Y. Safe separation of sputum cells from mucoid glycoprotein preserves surface antigen for immunocytochemistry and flow cytometry. Acta Cytol., 39: 1128-1136, 1995.
19. Sporn, M. B. Carcinogenesis and cancer. Different perspectives on the same disease. Cancer Res., 51: 6215-6218, 1991.
20. Stitik, F. P., Tockman, M. S., and Khoury, N. F. Chest radiology. In: A. B. Miller (ed.). Screening for Cancer, pp. 163-199. San Diego: Academic Press, 1985.
21. Tockman, M. S., Mulshine, J. L., Piantadosi, S., Erozan, Y. S., Gupta, P. K., Ruckdeschel, J., Taylor, P. R., Zhukov, T., Zhou, W-H., Qiao, Y-L., and Yao, S-X. Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression. Clin. Cancer Res., in press, 1997.
22. Ginsberg, R. J., Kris, M. G., and Armstrong, J. G. Cancer of the lung. In: V. T. DeVita, S. Hellman, and S. A. Rossenberg. (eds.). Cancer, Principles and Practice of Oncology pp. 673-679. Philadelphia: J. B. Lippincott Co., 1993.
23. Mulshine, J. L., Tockman, M. S., and Smart, C. R. Considerations in the development of lung cancer screening tools. J. Natl. Cancer Inst. (Bethesda), 81: 900-906, 1989.
24. Hong, W. K., Lippman, S. M., Itri, L. M., et al. Prevention of second primary tumors with isotretinoin in squamous cell carcinoma of the head and neck. N. Engl. J. Med., 323: 795-801, 1990.
25. Benner, S. E., Pajak, T. F., Lippman, S. M., Earley, C., and Hong, W. K. Prevention of second primary tumors with isotretinoin in patients with squamous cell carcinoma of the head and neck: long-term follow-up. J Natl. Cancer Inst. (Bethesda), 86: 140-141, 1994.
26. Pastorino, U., Infante, M., Maioli, M., et al. Adjuvant treatment of stage I lung cancer with high-dose vitamin A. J. Clin. Oncol., 11: 1216-1222, 1993.
27. Avis, I., Mathias, A., Unsworth, E. J., et al. Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability. Cell Growth Differ., 6: 485-492, 1995.